Feldman-Billard S
With compounded programs starting at $179 for the first month, patients gain access to physician review, a personalized plan, and medication shipped directly to their door
Plaintiffs allege that the drug, prescribed for type 2 diabetes and weight loss, caused serious gastrointestinal complications, including gastroparesis
Therefore, the prevalence of GLP-1 RAs users was 4.5% (7,511 of 165,860)
Janet Tomiyama, PhD, a health psychologist at the University of California, Los Angeles, wrote in a 2025 commentary, (GLP-1s) have the potential to increase weight stigma, medicalize larger bodies, and shame people for both taking the perceived easy way outor not taking it
Trial results look promising, but retatrutide is not FDA-approved